Clinical trials are a critical source of data for decisions around vaccine development. While MVI does not perform individual clinical trials, we seek to ensure that all clinical trials adhere to the highest scientific and ethical standards and are designed and run in a way that provides “supportable” data on the candidate. We also try to ensure that the trial is of a quality that will be accepted by regulatory agencies. Vaccine clinical trials assess the safety and efficacy of a new vaccine product, as well as its ability to provoke an immune response. Trials may also assess how well the product meshes with existing healthcare delivery systems, such as national immunization programs.
Tuesday, 6 October, 2015